Johnson & Johnson (JNJ) has begun late-stage trial of its COVID-19 vaccine candidate - CNBC
Notícias do Mercado
23 setembro 2020
Johnson & Johnson (JNJ) has begun late-stage trial of its COVID-19 vaccine candidate - CNBC
Johnson & Johnson is the fourth drugmaker backed by the Trump administration’s Covid-19 vaccine program Operation Warp Speed to enter late-stage testing, CNBC noted. The other companies are Moderna (MRNA), Pfizer (PFE) and AstraZeneca (AZN).
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer